Nuvalent Reports Key Milestones and Financial Progress for Q1 2025 In its recent update, Nuvalent highlights pivotal data expectations, successful leadership transitions, and solid financial results for Q1 2025.

Nuvalent Reports Key Milestones and Financial Progress for Q1 2025 #USA #Cambridge #Nuvalent #ROS1_Inhibitor #ALK_Program